Delivery Order SPE2DR25D3013-SPE2DR26F6S5K
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $35,697.41 by the Defense Logistics Agency for REPATHA 140 mg/ml SureClick auto-injector medication. The award was made on August 21, 2025, with an ultimate completion date of August 22, 2025, under a firm fixed-price delivery order structure with no set-aside designation. This competitive award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,880.79 by the Defense Logistics Agency on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract, issued under a firm fixed price arrangement, covers the supply of Repatha 140 mg/ml SureClick auto-injectors. This delivery order was competitively awarded with no set-aside designation and represents a child award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,932.71 by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed price, non-set-aside contract is scheduled for completion by August 20, 2025, and will be fulfilled at the company's Conshohocken facility. The award represents a child order under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,340.28 by the Defense Logistics Agency on August 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by August 5, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $7,351.22 by the Defense Logistics Agency on November 17, 2025, with an ultimate completion date of November 18, 2025. The contract covers the supply of Repatha 140 mg/ml SureClick auto-injector medication, with performance taking place at the company's Conshohocken facility. This delivery order was competitively awarded with no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,081.08 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. The contract employs firm fixed price pricing and carries an ultimate completion date of September 3, 2025, with performance to be executed at the contractor's Conshohocken, PA facility. This delivery order represents...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $8,646.68 by the Defense Logistics Agency for the supply of REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of November 4, 2025. This non-set-aside contract employs firm fixed pricing and represents a child delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to the company's corporate office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract from the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, valued at $16,549.76, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle...
- AmerisourceBergen Drug Corp received a delivery order contract valued at $16,610.81 from the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed price, competitively awarded contract is scheduled for completion by October 31, 2025, and will be fulfilled from the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order on November 4, 2025, by the Defense Logistics Agency for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a competitively awarded, firm fixed-price delivery order with a ceiling value of $15,222.77 and an ultimate completion date of November 5, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6S5KDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on November 17, 2025, for REPATHA 140 mg/mL SureClick auto-injector pharmaceutical products. The delivery order, valued at $9,661.02, represents a firm fixed-price contract with an ultimate completion date of November 18, 2025. This award was competitively awarded with no set-aside designation and functions as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support for military healthcare systems. AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement is well-established through its extensive portfolio of delivery orders with the DLA covering brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains. The company serves defense and civilian healthcare systems, including the Defense Health Agency and U.S. Coast Guard, through its flexible contract vehicles that enable rapid fulfillment of medical supply needs worldwide. This specific delivery order for REPATHA, a specialty pharmaceutical used in cholesterol management, exemplifies the company's capability to supply high-value branded medications essential to military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 11/17/25 |